MTEM - スレッシュ・ホ―ルド・ファ―マス―ティカルズ (Molecular Templates Inc.) スレッシュ・ホ―ルド・ファ―マス―ティカルズ

 MTEMのチャート


 MTEMの企業情報

symbol MTEM
会社名 Molecular Templates Inc (スレッシュ・ホ―ルド・ファ―マス―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 モレキュラー・テンプレート(Molecular Templates Inc.)(旧名:Threshold Pharmaceuticals Inc.)は臨床段階のバイオテクノロジー会社である。同社はがん患者の治療のために腫瘍細胞を選択的に標的とする治療剤及び診断剤の発見・開発に従事する。同社は低酸素活性化プロドラッグ技術に基づいて、エボフォスファミド及びタルオキソチニブ2つの治療薬候補を開発する。エボフォスファミドは、腫瘍によく見られる極度の低酸素状態で活性化されるが、健康な組織では活性化されないプロドラッグとして設計される。タルオキソチニブは変異EGFR陽性、T790M陰性進行NSCLCがEGFR TKIで進行する患者、及び頭部及び頸部の再発性または転移性の扁平上皮癌の患者のためのものという2つのフェーズIIの概念実証試験で調査される。[18F] -HX4は、低酸素症を同定するための陽電子放出断層撮影イメージング剤である。  スレッシュ・ホ―ルド・ファ―マス―ティカルズは米国のバイオ医薬品会社。腫瘍微小環境(間質細胞)を研究し、抗がん剤の開発を行う。内部組織肉腫、すい臓がん、黒色腫、骨髄腫、固形腫瘍の低酸素細胞をタ―ゲットにした活性プロドラッグを治験中。また、血管新生阻害による治療法の研究を行う。   
本社所在地 9301 Amberglen Blvd Suite 100 Austin TX 78729 USA
代表者氏名 Harold E. Selick ハロルドE.セリック
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 512-896-1555
設立年月日 37165
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 38人
url www.thresholdpharm.com
nasdaq_url https://www.nasdaq.com/symbol/mtem
adr_tso
EBITDA EBITDA(百万ドル) -32.04100
終値(lastsale) 5.51
時価総額(marketcap) 201088540.98
時価総額 時価総額(百万ドル) 171.03620
売上高 売上高(百万ドル) 3.31700
企業価値(EV) 企業価値(EV)(百万ドル) 133.31120
当期純利益 当期純利益(百万ドル) -36.42900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Molecular Templates Inc revenues decreased 4% to $1.8M. Net loss applicable to common stockholders increased from $6.1M to $18.4M. Revenues reflect Research and development revenue decrease of 33% to $1.2M. Higher net loss reflects Rese increase from $2.3M to $13.9M (expense) General and admi increase of 33% to $5.6M (expense) Stock Based Comp- Gen_Admin Exp increase from $51K to $1.1M (expense).

 MTEMのテクニカル分析


 MTEMのニュース

   Molecular Templates to Participate in Upcoming Virtual Investor Conferences  2020/11/16 21:30:00 GlobeNewswire
AUSTIN, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage…
   Oppenheimer Sees These 3 Stocks Skyrocketing Over 100%  2020/11/10 17:42:56 Yahoo Finance
The U.S. presidential election has come to a close, and Wall Street isn’t opposed to the administration change. Last week saw the S&P 500 notch its second-best performance during an election week on record, even as Trump’s chances of getting re-elected became slimer and slimer.Weighing in for Oppenheimer, Chief Investment Strategist John Stoltzfus noted, “What appears clear so far is that the equity markets are not averse to a change of administration stateside at least so long as the Republicans maintain control over the Senate. Checks and balances ‘on the Hill’ have been known to be important to investors over the course of history. The present in our view is no exception.”There is, however, some uncertainty surrounding the Senate, with the two runoff elections for seats in Georgia scheduled for January 5, only 15 days before Inauguration Day. That said, Stoltzfus points out that continued better-than-expected Q3 results from S&P 500-listed companies, economic data tied to job gains and a sharp decline in the unemployment rate have also been helping to prop stocks up.Taking Stoltzfus’ outlook into consideration, we wanted to take a closer look at three stocks earning a round of applause from Oppenheimer, with the firm’s analysts forecasting over 100% upside potential for each.
   Molecular Templates (NASDAQ:MTEM) Rating Lowered to Sell at BidaskClub  2020/10/22 07:42:47 Transcript Daily
Molecular Templates (NASDAQ:MTEM) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Tuesday, BidAskClub reports. MTEM has been the subject of a number of other reports. ValuEngine raised shares of Molecular Templates from a “hold” rating to a “buy” rating in a research […]
   BidaskClub Downgrades Molecular Templates (NASDAQ:MTEM) to Sell  2020/10/21 09:36:55 Zolmax News
BidaskClub lowered shares of Molecular Templates (NASDAQ:MTEM) from a hold rating to a sell rating in a research report report published on Tuesday, BidAskClub reports. A number of other equities analysts also recently issued reports on the company. Zacks Investment Research downgraded Molecular Templates from a hold rating to a sell rating in a research […]
   Zacks: Analysts Anticipate Molecular Templates, Inc. (NASDAQ:MTEM) to Post -$0.50 Earnings Per Share  2020/10/20 18:37:09 Transcript Daily
Equities research analysts predict that Molecular Templates, Inc. (NASDAQ:MTEM) will announce earnings of ($0.50) per share for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Molecular Templates’ earnings. The lowest EPS estimate is ($0.56) and the highest is ($0.46). Molecular Templates posted earnings of ($0.43) per share during the same quarter […]
   Molecular Templates (NASDAQ:MTEM) Rating Lowered to Sell at BidaskClub  2020/10/22 07:42:47 Transcript Daily
Molecular Templates (NASDAQ:MTEM) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Tuesday, BidAskClub reports. MTEM has been the subject of a number of other reports. ValuEngine raised shares of Molecular Templates from a “hold” rating to a “buy” rating in a research […]
   BidaskClub Downgrades Molecular Templates (NASDAQ:MTEM) to Sell  2020/10/21 09:36:55 Zolmax News
BidaskClub lowered shares of Molecular Templates (NASDAQ:MTEM) from a hold rating to a sell rating in a research report report published on Tuesday, BidAskClub reports. A number of other equities analysts also recently issued reports on the company. Zacks Investment Research downgraded Molecular Templates from a hold rating to a sell rating in a research […]
   Zacks: Analysts Anticipate Molecular Templates, Inc. (NASDAQ:MTEM) to Post -$0.50 Earnings Per Share  2020/10/20 18:37:09 Transcript Daily
Equities research analysts predict that Molecular Templates, Inc. (NASDAQ:MTEM) will announce earnings of ($0.50) per share for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Molecular Templates’ earnings. The lowest EPS estimate is ($0.56) and the highest is ($0.46). Molecular Templates posted earnings of ($0.43) per share during the same quarter […]
   $6.05 Million in Sales Expected for Molecular Templates, Inc. (NASDAQ:MTEM) This Quarter  2020/10/20 17:28:41 Transcript Daily
Equities analysts expect that Molecular Templates, Inc. (NASDAQ:MTEM) will report $6.05 million in sales for the current quarter, Zacks reports. Three analysts have provided estimates for Molecular Templates’ earnings, with estimates ranging from $5.00 million to $7.85 million. Molecular Templates reported sales of $3.62 million in the same quarter last year, which would suggest a […]
   Molecular Templates (NASDAQ:MTEM) Downgraded by BidaskClub  2020/10/20 02:18:46 Daily Political
Molecular Templates (NASDAQ:MTEM) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Tuesday, BidAskClub reports. A number of other equities research analysts have also issued reports on MTEM. ValuEngine upgraded Molecular Templates from a “hold” rating to a “buy” rating in a research note […]
   Molecular Templates (NASDAQ:MTEM) Rating Lowered to Sell at BidaskClub  2020/10/22 07:42:47 Transcript Daily
Molecular Templates (NASDAQ:MTEM) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Tuesday, BidAskClub reports. MTEM has been the subject of a number of other reports. ValuEngine raised shares of Molecular Templates from a “hold” rating to a “buy” rating in a research […]
   BidaskClub Downgrades Molecular Templates (NASDAQ:MTEM) to Sell  2020/10/21 09:36:55 Zolmax News
BidaskClub lowered shares of Molecular Templates (NASDAQ:MTEM) from a hold rating to a sell rating in a research report report published on Tuesday, BidAskClub reports. A number of other equities analysts also recently issued reports on the company. Zacks Investment Research downgraded Molecular Templates from a hold rating to a sell rating in a research […]
   Zacks: Analysts Anticipate Molecular Templates, Inc. (NASDAQ:MTEM) to Post -$0.50 Earnings Per Share  2020/10/20 18:37:09 Transcript Daily
Equities research analysts predict that Molecular Templates, Inc. (NASDAQ:MTEM) will announce earnings of ($0.50) per share for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Molecular Templates’ earnings. The lowest EPS estimate is ($0.56) and the highest is ($0.46). Molecular Templates posted earnings of ($0.43) per share during the same quarter […]
   $6.05 Million in Sales Expected for Molecular Templates, Inc. (NASDAQ:MTEM) This Quarter  2020/10/20 17:28:41 Transcript Daily
Equities analysts expect that Molecular Templates, Inc. (NASDAQ:MTEM) will report $6.05 million in sales for the current quarter, Zacks reports. Three analysts have provided estimates for Molecular Templates’ earnings, with estimates ranging from $5.00 million to $7.85 million. Molecular Templates reported sales of $3.62 million in the same quarter last year, which would suggest a […]
   Molecular Templates (NASDAQ:MTEM) Downgraded by BidaskClub  2020/10/20 02:18:46 Daily Political
Molecular Templates (NASDAQ:MTEM) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Tuesday, BidAskClub reports. A number of other equities research analysts have also issued reports on MTEM. ValuEngine upgraded Molecular Templates from a “hold” rating to a “buy” rating in a research note […]

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 スレッシュ・ホ―ルド・ファ―マス―ティカルズ MTEM Molecular Templates Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)